Zevra Therapeutics (ZVRA) announces CFO Resignation

On November 20, 2025, R. LaDuane Clifton, the Chief Financial Officer and Treasurer and principal financial officer of Zevra Therapeutics (NASDAQ: ZVRA) notified the Company of his decision to resign from his position, effective December 31, 2025 (the “Separation Date”), in order to pursue other professional opportunities.

You May Also Be Interested In

• Estée Lauder Companies names new brand leadership after retirement
• Trump: US Producing Munitions At Levels Never Seen Before
• SpaceX (SPCX) spreader of 3500 contracts of November 90 and 100 puts as share price up 5%